<?xml version="1.0" ?>
<addis-data>
	<indications id="0">
		<indication id="1" code="310497006" name="Severe depression"/>
	</indications>
	<endpoints id="2">
		<endpoint id="3" description="Responders with a 50% increase in HAM-D score" name="HAM-D Responders" unitOfMeasurement="Ratio of Patients">
			<direction value="HIGHER_IS_BETTER"/>
			<type value="RATE"/>
		</endpoint>
	</endpoints>
	<adverseEvents id="4">
		<adverseEvent id="5" description="" name="Diarrhea" unitOfMeasurement="Ratio of Patients">
			<direction value="LOWER_IS_BETTER"/>
			<type value="RATE"/>
		</adverseEvent>
		<adverseEvent id="6" description="" name="Dizziness" unitOfMeasurement="Ratio of Patients">
			<direction value="LOWER_IS_BETTER"/>
			<type value="RATE"/>
		</adverseEvent>
		<adverseEvent id="7" description="" name="Headache" unitOfMeasurement="Ratio of Patients">
			<direction value="LOWER_IS_BETTER"/>
			<type value="RATE"/>
		</adverseEvent>
		<adverseEvent id="8" description="" name="Insomnia" unitOfMeasurement="Ratio of Patients">
			<direction value="LOWER_IS_BETTER"/>
			<type value="RATE"/>
		</adverseEvent>
		<adverseEvent id="9" description="" name="Nausea" unitOfMeasurement="Ratio of Patients">
			<direction value="LOWER_IS_BETTER"/>
			<type value="RATE"/>
		</adverseEvent>
	</adverseEvents>
	<drugs id="10">
		<drug id="11" atcCode="Bupropion" name="Bupropion"/>
		<drug id="12" atcCode="Citalopram" name="Citalopram"/>
		<drug id="13" atcCode="Duloxetine" name="Duloxetine"/>
		<drug id="14" atcCode="Escitalopram" name="Escitalopram"/>
		<drug id="15" atcCode="Fluoxetine" name="Fluoxetine"/>
		<drug id="16" atcCode="Fluvoxamine" name="Fluvoxamine"/>
		<drug id="17" atcCode="Mirtazapine" name="Mirtazapine"/>
		<drug id="18" atcCode="Paroxetine" name="Paroxetine"/>
		<drug id="19" atcCode="Sertraline" name="Sertraline"/>
		<drug id="20" atcCode="Venlafaxine" name="Venlafaxine"/>
	</drugs>
	<populationCharacteristics id="21"/>
	<studies id="22">
		<study id="23" studyId="Aberg-Wistedt et al, 2000">
			<adverseEvents id="24">
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="25">
				<arm id="26" size="177">
					<dose class="fixedDose" id="27" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="28" size="176">
					<dose class="fixedDose" id="29" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="30" value="Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy"/>
			</characteristics>
			<endpoints id="31"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="32">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="26"/>
					<measurement class="rateMeasurement" id="33" rate="0" sampleSize="177"/>
				</measurement>
				<measurement id="34">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="28"/>
					<measurement class="rateMeasurement" id="35" rate="20" sampleSize="176"/>
				</measurement>
				<measurement id="36">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="28"/>
					<measurement class="rateMeasurement" id="37" rate="12" sampleSize="176"/>
				</measurement>
				<measurement id="38">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="28"/>
					<measurement class="rateMeasurement" id="39" rate="27" sampleSize="176"/>
				</measurement>
				<measurement id="40">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="26"/>
					<measurement class="rateMeasurement" id="41" rate="18" sampleSize="177"/>
				</measurement>
				<measurement id="42">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="28"/>
					<measurement class="rateMeasurement" id="43" rate="20" sampleSize="176"/>
				</measurement>
				<measurement id="44">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="26"/>
					<measurement class="rateMeasurement" id="45" rate="26" sampleSize="177"/>
				</measurement>
				<measurement id="46">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="26"/>
					<measurement class="rateMeasurement" id="47" rate="9" sampleSize="177"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="48"/>
		</study>
		<study id="49" studyId="Alves et al, 1999">
			<adverseEvents id="50">
				<adverseEvent ref="8"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="51">
				<arm id="52" size="40">
					<dose class="fixedDose" id="53" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="54" size="47">
					<dose class="fixedDose" id="55" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="56" value="Efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression"/>
			</characteristics>
			<endpoints id="57">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="58">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="54"/>
					<measurement class="rateMeasurement" id="59" rate="30" sampleSize="47"/>
				</measurement>
				<measurement id="60">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="54"/>
					<measurement class="rateMeasurement" id="61" rate="13" sampleSize="47"/>
				</measurement>
				<measurement id="62">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="54"/>
					<measurement class="rateMeasurement" id="63" rate="5" sampleSize="47"/>
				</measurement>
				<measurement id="64">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="52"/>
					<measurement class="rateMeasurement" id="65" rate="4" sampleSize="40"/>
				</measurement>
				<measurement id="66">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="52"/>
					<measurement class="rateMeasurement" id="67" rate="2" sampleSize="40"/>
				</measurement>
				<measurement id="68">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="54"/>
					<measurement class="rateMeasurement" id="69" rate="1" sampleSize="47"/>
				</measurement>
				<measurement id="70">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="52"/>
					<measurement class="rateMeasurement" id="71" rate="25" sampleSize="40"/>
				</measurement>
				<measurement id="72">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="52"/>
					<measurement class="rateMeasurement" id="73" rate="13" sampleSize="40"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="74"/>
		</study>
		<study id="75" studyId="Ballus et al, 2000">
			<adverseEvents id="76">
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="77">
				<arm id="78" size="41">
					<dose class="fixedDose" id="79" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="80" size="43">
					<dose class="fixedDose" id="81" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="82" value="The efficacy and tolerability of venlafaxine and fluoxetine in outpatients with depressive disorder or dysthymia"/>
			</characteristics>
			<endpoints id="83">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="84">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="78"/>
					<measurement class="rateMeasurement" id="85" rate="25" sampleSize="41"/>
				</measurement>
				<measurement id="86">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="80"/>
					<measurement class="rateMeasurement" id="87" rate="4" sampleSize="43"/>
				</measurement>
				<measurement id="88">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="80"/>
					<measurement class="rateMeasurement" id="89" rate="17" sampleSize="43"/>
				</measurement>
				<measurement id="90">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="78"/>
					<measurement class="rateMeasurement" id="91" rate="11" sampleSize="41"/>
				</measurement>
				<measurement id="92">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="78"/>
					<measurement class="rateMeasurement" id="93" rate="0" sampleSize="41"/>
				</measurement>
				<measurement id="94">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="80"/>
					<measurement class="rateMeasurement" id="95" rate="4" sampleSize="43"/>
				</measurement>
				<measurement id="96">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="78"/>
					<measurement class="rateMeasurement" id="97" rate="7" sampleSize="41"/>
				</measurement>
				<measurement id="98">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="80"/>
					<measurement class="rateMeasurement" id="99" rate="23" sampleSize="43"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="100"/>
		</study>
		<study id="101" studyId="Behnke et al, 2003">
			<adverseEvents id="102">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="103">
				<arm id="104" size="169">
					<dose class="fixedDose" id="105" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="106" size="176">
					<dose class="fixedDose" id="107" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="17"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="108" value="Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study"/>
			</characteristics>
			<endpoints id="109">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="110">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="111" rate="116" sampleSize="176"/>
				</measurement>
				<measurement id="112">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="113" rate="7" sampleSize="176"/>
				</measurement>
				<measurement id="114">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="115" rate="12" sampleSize="176"/>
				</measurement>
				<measurement id="116">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="117" rate="16" sampleSize="169"/>
				</measurement>
				<measurement id="118">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="119" rate="25" sampleSize="176"/>
				</measurement>
				<measurement id="120">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="121" rate="113" sampleSize="169"/>
				</measurement>
				<measurement id="122">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="123" rate="38" sampleSize="169"/>
				</measurement>
				<measurement id="124">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="125" rate="17" sampleSize="169"/>
				</measurement>
				<measurement id="126">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="127" rate="31" sampleSize="169"/>
				</measurement>
				<measurement id="128">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="104"/>
					<measurement class="rateMeasurement" id="129" rate="15" sampleSize="169"/>
				</measurement>
				<measurement id="130">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="131" rate="13" sampleSize="176"/>
				</measurement>
				<measurement id="132">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="106"/>
					<measurement class="rateMeasurement" id="133" rate="9" sampleSize="176"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="134"/>
		</study>
		<study id="135" studyId="Benkert et al, 2000">
			<adverseEvents id="136">
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="137">
				<arm id="138" size="134">
					<dose class="fixedDose" id="139" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="140" size="135">
					<dose class="fixedDose" id="141" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="17"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="142" value="Mirtazapine compared with paroxetine in major depression"/>
			</characteristics>
			<endpoints id="143">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="144">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="138"/>
					<measurement class="rateMeasurement" id="145" rate="14" sampleSize="134"/>
				</measurement>
				<measurement id="146">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="140"/>
					<measurement class="rateMeasurement" id="147" rate="13" sampleSize="135"/>
				</measurement>
				<measurement id="148">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="140"/>
					<measurement class="rateMeasurement" id="149" rate="12" sampleSize="135"/>
				</measurement>
				<measurement id="150">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="138"/>
					<measurement class="rateMeasurement" id="151" rate="11" sampleSize="134"/>
				</measurement>
				<measurement id="152">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="140"/>
					<measurement class="rateMeasurement" id="153" rate="11" sampleSize="135"/>
				</measurement>
				<measurement id="154">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="138"/>
					<measurement class="rateMeasurement" id="155" rate="11" sampleSize="134"/>
				</measurement>
				<measurement id="156">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="138"/>
					<measurement class="rateMeasurement" id="157" rate="72" sampleSize="134"/>
				</measurement>
				<measurement id="158">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="140"/>
					<measurement class="rateMeasurement" id="159" rate="79" sampleSize="135"/>
				</measurement>
				<measurement id="160">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="138"/>
					<measurement class="rateMeasurement" id="161" rate="15" sampleSize="134"/>
				</measurement>
				<measurement id="162">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="140"/>
					<measurement class="rateMeasurement" id="163" rate="6" sampleSize="135"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="164"/>
		</study>
		<study id="165" studyId="Bennie et al, 1995">
			<adverseEvents id="166">
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="167">
				<arm id="168" size="142">
					<dose class="fixedDose" id="169" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="170" size="144">
					<dose class="fixedDose" id="171" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="172" value="A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression"/>
			</characteristics>
			<endpoints id="173">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="174">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="168"/>
					<measurement class="rateMeasurement" id="175" rate="7" sampleSize="142"/>
				</measurement>
				<measurement id="176">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="168"/>
					<measurement class="rateMeasurement" id="177" rate="2" sampleSize="142"/>
				</measurement>
				<measurement id="178">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="170"/>
					<measurement class="rateMeasurement" id="179" rate="8" sampleSize="144"/>
				</measurement>
				<measurement id="180">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="168"/>
					<measurement class="rateMeasurement" id="181" rate="73" sampleSize="142"/>
				</measurement>
				<measurement id="182">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="168"/>
					<measurement class="rateMeasurement" id="183" rate="30" sampleSize="142"/>
				</measurement>
				<measurement id="184">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="170"/>
					<measurement class="rateMeasurement" id="185" rate="36" sampleSize="144"/>
				</measurement>
				<measurement id="186">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="170"/>
					<measurement class="rateMeasurement" id="187" rate="21" sampleSize="144"/>
				</measurement>
				<measurement id="188">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="170"/>
					<measurement class="rateMeasurement" id="189" rate="63" sampleSize="144"/>
				</measurement>
				<measurement id="190">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="168"/>
					<measurement class="rateMeasurement" id="191" rate="20" sampleSize="142"/>
				</measurement>
				<measurement id="192">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="170"/>
					<measurement class="rateMeasurement" id="193" rate="5" sampleSize="144"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="194"/>
		</study>
		<study id="195" studyId="Bielski et al, 2004">
			<adverseEvents id="196">
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="197">
				<arm id="198" size="100">
					<dose class="fixedDose" id="199" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="200" size="98">
					<dose class="fixedDose" id="201" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="14"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="202" value="A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder"/>
			</characteristics>
			<endpoints id="203">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="204">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="198"/>
					<measurement class="rateMeasurement" id="205" rate="47" sampleSize="100"/>
				</measurement>
				<measurement id="206">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="200"/>
					<measurement class="rateMeasurement" id="207" rate="6" sampleSize="98"/>
				</measurement>
				<measurement id="208">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="198"/>
					<measurement class="rateMeasurement" id="209" rate="14" sampleSize="100"/>
				</measurement>
				<measurement id="210">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="198"/>
					<measurement class="rateMeasurement" id="211" rate="24" sampleSize="100"/>
				</measurement>
				<measurement id="212">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="200"/>
					<measurement class="rateMeasurement" id="213" rate="59" sampleSize="98"/>
				</measurement>
				<measurement id="214">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="200"/>
					<measurement class="rateMeasurement" id="215" rate="15" sampleSize="98"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="216"/>
		</study>
		<study id="217" studyId="Boyer et al, 1998">
			<adverseEvents id="218"/>
			<arms id="219">
				<arm id="220" size="122">
					<dose class="fixedDose" id="221" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="222" size="120">
					<dose class="fixedDose" id="223" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="224" value="Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France."/>
			</characteristics>
			<endpoints id="225">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="226">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="222"/>
					<measurement class="rateMeasurement" id="227" rate="61" sampleSize="120"/>
				</measurement>
				<measurement id="228">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="220"/>
					<measurement class="rateMeasurement" id="229" rate="63" sampleSize="122"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="230"/>
		</study>
		<study id="231" studyId="Burke et al, 2002">
			<adverseEvents id="232">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="233">
				<arm id="234" size="125">
					<dose class="fixedDose" id="235" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="12"/>
				</arm>
				<arm id="236" size="125">
					<dose class="fixedDose" id="237" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="14"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="238" value="A fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients"/>
			</characteristics>
			<endpoints id="239"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="240">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="234"/>
					<measurement class="rateMeasurement" id="241" rate="14" sampleSize="125"/>
				</measurement>
				<measurement id="242">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="236"/>
					<measurement class="rateMeasurement" id="243" rate="18" sampleSize="125"/>
				</measurement>
				<measurement id="244">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="234"/>
					<measurement class="rateMeasurement" id="245" rate="28" sampleSize="125"/>
				</measurement>
				<measurement id="246">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="234"/>
					<measurement class="rateMeasurement" id="247" rate="14" sampleSize="125"/>
				</measurement>
				<measurement id="248">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="236"/>
					<measurement class="rateMeasurement" id="249" rate="18" sampleSize="125"/>
				</measurement>
				<measurement id="250">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="236"/>
					<measurement class="rateMeasurement" id="251" rate="18" sampleSize="125"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="252"/>
		</study>
		<study id="253" studyId="Chouinard et al, 1999">
			<adverseEvents id="254">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="255">
				<arm id="256" size="102">
					<dose class="fixedDose" id="257" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="258" size="101">
					<dose class="fixedDose" id="259" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="260" value="A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder"/>
			</characteristics>
			<endpoints id="261">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="262">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="258"/>
					<measurement class="rateMeasurement" id="263" rate="19" sampleSize="101"/>
				</measurement>
				<measurement id="264">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="258"/>
					<measurement class="rateMeasurement" id="265" rate="67" sampleSize="101"/>
				</measurement>
				<measurement id="266">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="256"/>
					<measurement class="rateMeasurement" id="267" rate="12" sampleSize="102"/>
				</measurement>
				<measurement id="268">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="258"/>
					<measurement class="rateMeasurement" id="269" rate="32" sampleSize="101"/>
				</measurement>
				<measurement id="270">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="256"/>
					<measurement class="rateMeasurement" id="271" rate="27" sampleSize="102"/>
				</measurement>
				<measurement id="272">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="256"/>
					<measurement class="rateMeasurement" id="273" rate="38" sampleSize="102"/>
				</measurement>
				<measurement id="274">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="258"/>
					<measurement class="rateMeasurement" id="275" rate="23" sampleSize="101"/>
				</measurement>
				<measurement id="276">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="256"/>
					<measurement class="rateMeasurement" id="277" rate="67" sampleSize="102"/>
				</measurement>
				<measurement id="278">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="258"/>
					<measurement class="rateMeasurement" id="279" rate="37" sampleSize="101"/>
				</measurement>
				<measurement id="280">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="256"/>
					<measurement class="rateMeasurement" id="281" rate="37" sampleSize="102"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="282"/>
		</study>
		<study id="283" studyId="Coleman et al, 1999">
			<adverseEvents id="284">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="285">
				<arm id="286" size="118">
					<dose class="fixedDose" id="287" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="288" size="122">
					<dose class="fixedDose" id="289" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="290" value="Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment."/>
			</characteristics>
			<endpoints id="291">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="292">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="288"/>
					<measurement class="rateMeasurement" id="293" rate="40" sampleSize="122"/>
				</measurement>
				<measurement id="294">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="288"/>
					<measurement class="rateMeasurement" id="295" rate="23" sampleSize="122"/>
				</measurement>
				<measurement id="296">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="288"/>
					<measurement class="rateMeasurement" id="297" rate="24" sampleSize="122"/>
				</measurement>
				<measurement id="298">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="286"/>
					<measurement class="rateMeasurement" id="299" rate="26" sampleSize="118"/>
				</measurement>
				<measurement id="300">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="288"/>
					<measurement class="rateMeasurement" id="301" rate="81" sampleSize="122"/>
				</measurement>
				<measurement id="302">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="286"/>
					<measurement class="rateMeasurement" id="303" rate="21" sampleSize="118"/>
				</measurement>
				<measurement id="304">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="286"/>
					<measurement class="rateMeasurement" id="305" rate="20" sampleSize="118"/>
				</measurement>
				<measurement id="306">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="286"/>
					<measurement class="rateMeasurement" id="307" rate="72" sampleSize="118"/>
				</measurement>
				<measurement id="308">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="288"/>
					<measurement class="rateMeasurement" id="309" rate="14" sampleSize="122"/>
				</measurement>
				<measurement id="310">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="286"/>
					<measurement class="rateMeasurement" id="311" rate="31" sampleSize="118"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="312"/>
		</study>
		<study id="313" studyId="Coleman et al, 2001">
			<adverseEvents id="314">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="315">
				<arm id="316" size="154">
					<dose class="fixedDose" id="317" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
				<arm id="318" size="150">
					<dose class="fixedDose" id="319" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="320" value="A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine"/>
			</characteristics>
			<endpoints id="321">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="322">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="316"/>
					<measurement class="rateMeasurement" id="323" rate="18" sampleSize="154"/>
				</measurement>
				<measurement id="324">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="318"/>
					<measurement class="rateMeasurement" id="325" rate="42" sampleSize="150"/>
				</measurement>
				<measurement id="326">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="318"/>
					<measurement class="rateMeasurement" id="327" rate="21" sampleSize="150"/>
				</measurement>
				<measurement id="328">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="318"/>
					<measurement class="rateMeasurement" id="329" rate="13" sampleSize="150"/>
				</measurement>
				<measurement id="330">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="316"/>
					<measurement class="rateMeasurement" id="331" rate="15" sampleSize="154"/>
				</measurement>
				<measurement id="332">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="316"/>
					<measurement class="rateMeasurement" id="333" rate="47" sampleSize="154"/>
				</measurement>
				<measurement id="334">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="316"/>
					<measurement class="rateMeasurement" id="335" rate="88" sampleSize="154"/>
				</measurement>
				<measurement id="336">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="316"/>
					<measurement class="rateMeasurement" id="337" rate="18" sampleSize="154"/>
				</measurement>
				<measurement id="338">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="318"/>
					<measurement class="rateMeasurement" id="339" rate="84" sampleSize="150"/>
				</measurement>
				<measurement id="340">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="318"/>
					<measurement class="rateMeasurement" id="341" rate="32" sampleSize="150"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="342"/>
		</study>
		<study id="343" studyId="Croft et al, 1999">
			<adverseEvents id="344">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="345">
				<arm id="346" size="119">
					<dose class="fixedDose" id="347" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="348" size="120">
					<dose class="fixedDose" id="349" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="350" value="A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline."/>
			</characteristics>
			<endpoints id="351">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="352">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="348"/>
					<measurement class="rateMeasurement" id="353" rate="40" sampleSize="120"/>
				</measurement>
				<measurement id="354">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="346"/>
					<measurement class="rateMeasurement" id="355" rate="37" sampleSize="119"/>
				</measurement>
				<measurement id="356">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="348"/>
					<measurement class="rateMeasurement" id="357" rate="8" sampleSize="120"/>
				</measurement>
				<measurement id="358">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="348"/>
					<measurement class="rateMeasurement" id="359" rate="79" sampleSize="120"/>
				</measurement>
				<measurement id="360">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="346"/>
					<measurement class="rateMeasurement" id="361" rate="47" sampleSize="119"/>
				</measurement>
				<measurement id="362">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="346"/>
					<measurement class="rateMeasurement" id="363" rate="81" sampleSize="119"/>
				</measurement>
				<measurement id="364">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="348"/>
					<measurement class="rateMeasurement" id="365" rate="21" sampleSize="120"/>
				</measurement>
				<measurement id="366">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="346"/>
					<measurement class="rateMeasurement" id="367" rate="21" sampleSize="119"/>
				</measurement>
				<measurement id="368">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="346"/>
					<measurement class="rateMeasurement" id="369" rate="31" sampleSize="119"/>
				</measurement>
				<measurement id="370">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="348"/>
					<measurement class="rateMeasurement" id="371" rate="15" sampleSize="120"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="372"/>
		</study>
		<study id="373" studyId="Dalery and Honig, 2003">
			<adverseEvents id="374">
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="375">
				<arm id="376" size="90">
					<dose class="fixedDose" id="377" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="16"/>
				</arm>
				<arm id="378" size="94">
					<dose class="fixedDose" id="379" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="380" value="Fluvoxamine versus fluoxetine in major depressive episodes: a double-blind randomised comparison"/>
			</characteristics>
			<endpoints id="381">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="382">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="376"/>
					<measurement class="rateMeasurement" id="383" rate="13" sampleSize="90"/>
				</measurement>
				<measurement id="384">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="378"/>
					<measurement class="rateMeasurement" id="385" rate="56" sampleSize="94"/>
				</measurement>
				<measurement id="386">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="378"/>
					<measurement class="rateMeasurement" id="387" rate="20" sampleSize="94"/>
				</measurement>
				<measurement id="388">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="376"/>
					<measurement class="rateMeasurement" id="389" rate="54" sampleSize="90"/>
				</measurement>
				<measurement id="390">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="376"/>
					<measurement class="rateMeasurement" id="391" rate="2" sampleSize="90"/>
				</measurement>
				<measurement id="392">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="378"/>
					<measurement class="rateMeasurement" id="393" rate="14" sampleSize="94"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="394"/>
		</study>
		<study id="395" studyId="De Nayer et al, 2002">
			<adverseEvents id="396">
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="397">
				<arm id="398" size="73">
					<dose class="fixedDose" id="399" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="400" size="73">
					<dose class="fixedDose" id="401" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="402" value="Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety."/>
			</characteristics>
			<endpoints id="403">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="404">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="398"/>
					<measurement class="rateMeasurement" id="405" rate="21" sampleSize="73"/>
				</measurement>
				<measurement id="406">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="400"/>
					<measurement class="rateMeasurement" id="407" rate="8" sampleSize="73"/>
				</measurement>
				<measurement id="408">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="398"/>
					<measurement class="rateMeasurement" id="409" rate="37" sampleSize="73"/>
				</measurement>
				<measurement id="410">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="400"/>
					<measurement class="rateMeasurement" id="411" rate="27" sampleSize="73"/>
				</measurement>
				<measurement id="412">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="400"/>
					<measurement class="rateMeasurement" id="413" rate="16" sampleSize="73"/>
				</measurement>
				<measurement id="414">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="398"/>
					<measurement class="rateMeasurement" id="415" rate="6" sampleSize="73"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="416"/>
		</study>
		<study id="417" studyId="De Wilde et al, 1993">
			<adverseEvents id="418">
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="419">
				<arm id="420" size="37">
					<dose class="fixedDose" id="421" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="422" size="41">
					<dose class="fixedDose" id="423" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="424" value="A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients."/>
			</characteristics>
			<endpoints id="425"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="426">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="420"/>
					<measurement class="rateMeasurement" id="427" rate="10" sampleSize="37"/>
				</measurement>
				<measurement id="428">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="422"/>
					<measurement class="rateMeasurement" id="429" rate="10" sampleSize="41"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="430"/>
		</study>
		<study id="431" studyId="Detke et al, 2004">
			<adverseEvents id="432">
				<adverseEvent ref="8"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="433">
				<arm id="434" size="86">
					<dose class="fixedDose" id="435" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="436" size="93">
					<dose class="fixedDose" id="437" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="13"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="438" value="Duloxetine in the accute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial"/>
			</characteristics>
			<endpoints id="439">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="440">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="436"/>
					<measurement class="rateMeasurement" id="441" rate="5" sampleSize="93"/>
				</measurement>
				<measurement id="442">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="434"/>
					<measurement class="rateMeasurement" id="443" rate="4" sampleSize="86"/>
				</measurement>
				<measurement id="444">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="436"/>
					<measurement class="rateMeasurement" id="445" rate="5" sampleSize="93"/>
				</measurement>
				<measurement id="446">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="434"/>
					<measurement class="rateMeasurement" id="447" rate="3" sampleSize="86"/>
				</measurement>
				<measurement id="448">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="436"/>
					<measurement class="rateMeasurement" id="449" rate="66" sampleSize="93"/>
				</measurement>
				<measurement id="450">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="434"/>
					<measurement class="rateMeasurement" id="451" rate="10" sampleSize="86"/>
				</measurement>
				<measurement id="452">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="434"/>
					<measurement class="rateMeasurement" id="453" rate="63" sampleSize="86"/>
				</measurement>
				<measurement id="454">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="436"/>
					<measurement class="rateMeasurement" id="455" rate="5" sampleSize="93"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="456"/>
		</study>
		<study id="457" studyId="Dierick et al, 1996">
			<adverseEvents id="458">
				<adverseEvent ref="8"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="459">
				<arm id="460" size="153">
					<dose class="fixedDose" id="461" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="462" size="161">
					<dose class="fixedDose" id="463" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="464" value="A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients."/>
			</characteristics>
			<endpoints id="465">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="466">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="462"/>
					<measurement class="rateMeasurement" id="467" rate="13" sampleSize="161"/>
				</measurement>
				<measurement id="468">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="460"/>
					<measurement class="rateMeasurement" id="469" rate="11" sampleSize="153"/>
				</measurement>
				<measurement id="470">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="462"/>
					<measurement class="rateMeasurement" id="471" rate="20" sampleSize="161"/>
				</measurement>
				<measurement id="472">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="460"/>
					<measurement class="rateMeasurement" id="473" rate="43" sampleSize="153"/>
				</measurement>
				<measurement id="474">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="460"/>
					<measurement class="rateMeasurement" id="475" rate="15" sampleSize="153"/>
				</measurement>
				<measurement id="476">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="460"/>
					<measurement class="rateMeasurement" id="477" rate="107" sampleSize="153"/>
				</measurement>
				<measurement id="478">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="462"/>
					<measurement class="rateMeasurement" id="479" rate="95" sampleSize="161"/>
				</measurement>
				<measurement id="480">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="462"/>
					<measurement class="rateMeasurement" id="481" rate="23" sampleSize="161"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="482"/>
		</study>
		<study id="483" studyId="Ekselius et al, 1997">
			<adverseEvents id="484">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="485">
				<arm id="486" size="200">
					<dose class="fixedDose" id="487" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="12"/>
				</arm>
				<arm id="488" size="200">
					<dose class="fixedDose" id="489" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="490" value="A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice."/>
			</characteristics>
			<endpoints id="491">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="492">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="493" rate="14" sampleSize="200"/>
				</measurement>
				<measurement id="494">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="495" rate="11" sampleSize="200"/>
				</measurement>
				<measurement id="496">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="497" rate="5" sampleSize="200"/>
				</measurement>
				<measurement id="498">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="499" rate="12" sampleSize="200"/>
				</measurement>
				<measurement id="500">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="501" rate="162" sampleSize="200"/>
				</measurement>
				<measurement id="502">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="503" rate="18" sampleSize="200"/>
				</measurement>
				<measurement id="504">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="505" rate="14" sampleSize="200"/>
				</measurement>
				<measurement id="506">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="507" rate="13" sampleSize="200"/>
				</measurement>
				<measurement id="508">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="509" rate="10" sampleSize="200"/>
				</measurement>
				<measurement id="510">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="511" rate="151" sampleSize="200"/>
				</measurement>
				<measurement id="512">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="486"/>
					<measurement class="rateMeasurement" id="513" rate="9" sampleSize="200"/>
				</measurement>
				<measurement id="514">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="488"/>
					<measurement class="rateMeasurement" id="515" rate="17" sampleSize="200"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="516"/>
		</study>
		<study id="517" studyId="Fava et al, 1998">
			<adverseEvents id="518"/>
			<arms id="519">
				<arm id="520" size="55">
					<dose class="fixedDose" id="521" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="522" size="54">
					<dose class="fixedDose" id="523" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="524" value="A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression"/>
			</characteristics>
			<endpoints id="525">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="526">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="522"/>
					<measurement class="rateMeasurement" id="527" rate="31" sampleSize="54"/>
				</measurement>
				<measurement id="528">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="520"/>
					<measurement class="rateMeasurement" id="529" rate="32" sampleSize="55"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="530"/>
		</study>
		<study id="531" studyId="Fava et al, 2002">
			<adverseEvents id="532">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="533">
				<arm id="534" size="96">
					<dose class="fixedDose" id="535" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="536" size="96">
					<dose class="fixedDose" id="537" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="538" size="92">
					<dose class="fixedDose" id="539" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="540" value="Accute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia"/>
			</characteristics>
			<endpoints id="541">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="542">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="538"/>
					<measurement class="rateMeasurement" id="543" rate="0" sampleSize="92"/>
				</measurement>
				<measurement id="544">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="538"/>
					<measurement class="rateMeasurement" id="545" rate="22" sampleSize="92"/>
				</measurement>
				<measurement id="546">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="538"/>
					<measurement class="rateMeasurement" id="547" rate="0" sampleSize="92"/>
				</measurement>
				<measurement id="548">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="536"/>
					<measurement class="rateMeasurement" id="549" rate="23" sampleSize="96"/>
				</measurement>
				<measurement id="550">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="534"/>
					<measurement class="rateMeasurement" id="551" rate="20" sampleSize="96"/>
				</measurement>
				<measurement id="552">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="536"/>
					<measurement class="rateMeasurement" id="553" rate="20" sampleSize="96"/>
				</measurement>
				<measurement id="554">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="534"/>
					<measurement class="rateMeasurement" id="555" rate="27" sampleSize="96"/>
				</measurement>
				<measurement id="556">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="538"/>
					<measurement class="rateMeasurement" id="557" rate="0" sampleSize="92"/>
				</measurement>
				<measurement id="558">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="536"/>
					<measurement class="rateMeasurement" id="559" rate="0" sampleSize="96"/>
				</measurement>
				<measurement id="560">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="534"/>
					<measurement class="rateMeasurement" id="561" rate="25" sampleSize="96"/>
				</measurement>
				<measurement id="562">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="534"/>
					<measurement class="rateMeasurement" id="563" rate="70" sampleSize="96"/>
				</measurement>
				<measurement id="564">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="538"/>
					<measurement class="rateMeasurement" id="565" rate="57" sampleSize="92"/>
				</measurement>
				<measurement id="566">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="536"/>
					<measurement class="rateMeasurement" id="567" rate="64" sampleSize="96"/>
				</measurement>
				<measurement id="568">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="534"/>
					<measurement class="rateMeasurement" id="569" rate="25" sampleSize="96"/>
				</measurement>
				<measurement id="570">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="536"/>
					<measurement class="rateMeasurement" id="571" rate="19" sampleSize="96"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="572"/>
		</study>
		<study id="573" studyId="Feighner et al, 1991">
			<adverseEvents id="574">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="575">
				<arm id="576" size="62">
					<dose class="fixedDose" id="577" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
				<arm id="578" size="61">
					<dose class="fixedDose" id="579" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="580" value="Double-blind comparison of bupropion and fluoxetine in depressed outpatients"/>
			</characteristics>
			<endpoints id="581">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="582">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="583" rate="10" sampleSize="62"/>
				</measurement>
				<measurement id="584">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="585" rate="0" sampleSize="61"/>
				</measurement>
				<measurement id="586">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="587" rate="10" sampleSize="61"/>
				</measurement>
				<measurement id="588">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="589" rate="3" sampleSize="62"/>
				</measurement>
				<measurement id="590">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="591" rate="6" sampleSize="61"/>
				</measurement>
				<measurement id="592">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="593" rate="6" sampleSize="62"/>
				</measurement>
				<measurement id="594">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="595" rate="35" sampleSize="62"/>
				</measurement>
				<measurement id="596">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="597" rate="9" sampleSize="61"/>
				</measurement>
				<measurement id="598">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="599" rate="7" sampleSize="62"/>
				</measurement>
				<measurement id="600">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="601" rate="37" sampleSize="61"/>
				</measurement>
				<measurement id="602">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="576"/>
					<measurement class="rateMeasurement" id="603" rate="4" sampleSize="62"/>
				</measurement>
				<measurement id="604">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="578"/>
					<measurement class="rateMeasurement" id="605" rate="4" sampleSize="61"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="606"/>
		</study>
		<study id="607" studyId="Franchini et al, 1997">
			<adverseEvents id="608">
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="609">
				<arm id="610" size="32">
					<dose class="fixedDose" id="611" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="612" size="32">
					<dose class="fixedDose" id="613" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="16"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="614" value="A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression."/>
			</characteristics>
			<endpoints id="615"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="616">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="610"/>
					<measurement class="rateMeasurement" id="617" rate="0" sampleSize="32"/>
				</measurement>
				<measurement id="618">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="612"/>
					<measurement class="rateMeasurement" id="619" rate="3" sampleSize="32"/>
				</measurement>
				<measurement id="620">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="612"/>
					<measurement class="rateMeasurement" id="621" rate="1" sampleSize="32"/>
				</measurement>
				<measurement id="622">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="610"/>
					<measurement class="rateMeasurement" id="623" rate="2" sampleSize="32"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="624"/>
		</study>
		<study id="625" studyId="Gagiano 1993">
			<adverseEvents id="626">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="627">
				<arm id="628" size="45">
					<dose class="fixedDose" id="629" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="630" size="45">
					<dose class="fixedDose" id="631" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="632" value="A double blind comparison of paroxetine and fluoxetine in patients with major depression"/>
			</characteristics>
			<endpoints id="633">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="634">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="630"/>
					<measurement class="rateMeasurement" id="635" rate="15" sampleSize="45"/>
				</measurement>
				<measurement id="636">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="630"/>
					<measurement class="rateMeasurement" id="637" rate="21" sampleSize="45"/>
				</measurement>
				<measurement id="638">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="630"/>
					<measurement class="rateMeasurement" id="639" rate="9" sampleSize="45"/>
				</measurement>
				<measurement id="640">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="628"/>
					<measurement class="rateMeasurement" id="641" rate="16" sampleSize="45"/>
				</measurement>
				<measurement id="642">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="630"/>
					<measurement class="rateMeasurement" id="643" rate="27" sampleSize="45"/>
				</measurement>
				<measurement id="644">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="628"/>
					<measurement class="rateMeasurement" id="645" rate="24" sampleSize="45"/>
				</measurement>
				<measurement id="646">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="630"/>
					<measurement class="rateMeasurement" id="647" rate="6" sampleSize="45"/>
				</measurement>
				<measurement id="648">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="628"/>
					<measurement class="rateMeasurement" id="649" rate="5" sampleSize="45"/>
				</measurement>
				<measurement id="650">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="628"/>
					<measurement class="rateMeasurement" id="651" rate="30" sampleSize="45"/>
				</measurement>
				<measurement id="652">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="628"/>
					<measurement class="rateMeasurement" id="653" rate="6" sampleSize="45"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="654"/>
		</study>
		<study id="655" studyId="Goldstein et al, 2002">
			<adverseEvents id="656">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="657">
				<arm id="658" size="33">
					<dose class="fixedDose" id="659" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
				<arm id="660" size="70">
					<dose class="fixedDose" id="661" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="13"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="662" value="Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial"/>
			</characteristics>
			<endpoints id="663">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="664">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="665" rate="9" sampleSize="70"/>
				</measurement>
				<measurement id="666">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="667" rate="11" sampleSize="33"/>
				</measurement>
				<measurement id="668">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="669" rate="14" sampleSize="70"/>
				</measurement>
				<measurement id="670">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="671" rate="14" sampleSize="70"/>
				</measurement>
				<measurement id="672">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="673" rate="6" sampleSize="33"/>
				</measurement>
				<measurement id="674">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="675" rate="17" sampleSize="33"/>
				</measurement>
				<measurement id="676">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="677" rate="11" sampleSize="70"/>
				</measurement>
				<measurement id="678">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="679" rate="3" sampleSize="33"/>
				</measurement>
				<measurement id="680">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="681" rate="10" sampleSize="70"/>
				</measurement>
				<measurement id="682">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="660"/>
					<measurement class="rateMeasurement" id="683" rate="42" sampleSize="70"/>
				</measurement>
				<measurement id="684">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="685" rate="2" sampleSize="33"/>
				</measurement>
				<measurement id="686">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="658"/>
					<measurement class="rateMeasurement" id="687" rate="10" sampleSize="33"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="688"/>
		</study>
		<study id="689" studyId="Hong et al, 2003">
			<adverseEvents id="690">
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="691">
				<arm id="692" size="66">
					<dose class="fixedDose" id="693" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
				<arm id="694" size="66">
					<dose class="fixedDose" id="695" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="17"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="696" value="A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed chinese patients"/>
			</characteristics>
			<endpoints id="697">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="698">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="694"/>
					<measurement class="rateMeasurement" id="699" rate="0" sampleSize="66"/>
				</measurement>
				<measurement id="700">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="694"/>
					<measurement class="rateMeasurement" id="701" rate="5" sampleSize="66"/>
				</measurement>
				<measurement id="702">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="694"/>
					<measurement class="rateMeasurement" id="703" rate="13" sampleSize="66"/>
				</measurement>
				<measurement id="704">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="692"/>
					<measurement class="rateMeasurement" id="705" rate="34" sampleSize="66"/>
				</measurement>
				<measurement id="706">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="692"/>
					<measurement class="rateMeasurement" id="707" rate="4" sampleSize="66"/>
				</measurement>
				<measurement id="708">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="694"/>
					<measurement class="rateMeasurement" id="709" rate="38" sampleSize="66"/>
				</measurement>
				<measurement id="710">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="692"/>
					<measurement class="rateMeasurement" id="711" rate="9" sampleSize="66"/>
				</measurement>
				<measurement id="712">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="692"/>
					<measurement class="rateMeasurement" id="713" rate="8" sampleSize="66"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="714"/>
		</study>
		<study id="715" studyId="Kavoussi et al, 1997">
			<adverseEvents id="716">
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="717">
				<arm id="718" size="126">
					<dose class="fixedDose" id="719" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="720" size="122">
					<dose class="fixedDose" id="721" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="722" value="Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients."/>
			</characteristics>
			<endpoints id="723"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="724">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="718"/>
					<measurement class="rateMeasurement" id="725" rate="40" sampleSize="126"/>
				</measurement>
				<measurement id="726">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="720"/>
					<measurement class="rateMeasurement" id="727" rate="12" sampleSize="122"/>
				</measurement>
				<measurement id="728">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="718"/>
					<measurement class="rateMeasurement" id="729" rate="28" sampleSize="126"/>
				</measurement>
				<measurement id="730">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="720"/>
					<measurement class="rateMeasurement" id="731" rate="41" sampleSize="122"/>
				</measurement>
				<measurement id="732">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="720"/>
					<measurement class="rateMeasurement" id="733" rate="4" sampleSize="122"/>
				</measurement>
				<measurement id="734">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="718"/>
					<measurement class="rateMeasurement" id="735" rate="37" sampleSize="126"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="736"/>
		</study>
		<study id="737" studyId="Kiev and Feiger, 1997">
			<adverseEvents id="738">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="739">
				<arm id="740" size="30">
					<dose class="fixedDose" id="741" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="16"/>
				</arm>
				<arm id="742" size="30">
					<dose class="fixedDose" id="743" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="744" value="A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients"/>
			</characteristics>
			<endpoints id="745"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="746">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="740"/>
					<measurement class="rateMeasurement" id="747" rate="9" sampleSize="30"/>
				</measurement>
				<measurement id="748">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="742"/>
					<measurement class="rateMeasurement" id="749" rate="8" sampleSize="30"/>
				</measurement>
				<measurement id="750">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="742"/>
					<measurement class="rateMeasurement" id="751" rate="9" sampleSize="30"/>
				</measurement>
				<measurement id="752">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="740"/>
					<measurement class="rateMeasurement" id="753" rate="4" sampleSize="30"/>
				</measurement>
				<measurement id="754">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="740"/>
					<measurement class="rateMeasurement" id="755" rate="12" sampleSize="30"/>
				</measurement>
				<measurement id="756">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="742"/>
					<measurement class="rateMeasurement" id="757" rate="17" sampleSize="30"/>
				</measurement>
				<measurement id="758">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="742"/>
					<measurement class="rateMeasurement" id="759" rate="6" sampleSize="30"/>
				</measurement>
				<measurement id="760">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="742"/>
					<measurement class="rateMeasurement" id="761" rate="14" sampleSize="30"/>
				</measurement>
				<measurement id="762">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="740"/>
					<measurement class="rateMeasurement" id="763" rate="11" sampleSize="30"/>
				</measurement>
				<measurement id="764">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="740"/>
					<measurement class="rateMeasurement" id="765" rate="6" sampleSize="30"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="766"/>
		</study>
		<study id="767" studyId="Lepola et al, 2003">
			<adverseEvents id="768">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="769">
				<arm id="770" size="160">
					<dose class="fixedDose" id="771" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="12"/>
				</arm>
				<arm id="772" size="155">
					<dose class="fixedDose" id="773" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="14"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="774" value="Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care."/>
			</characteristics>
			<endpoints id="775"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="776">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="772"/>
					<measurement class="rateMeasurement" id="777" rate="3" sampleSize="155"/>
				</measurement>
				<measurement id="778">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="770"/>
					<measurement class="rateMeasurement" id="779" rate="10" sampleSize="160"/>
				</measurement>
				<measurement id="780">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="772"/>
					<measurement class="rateMeasurement" id="781" rate="14" sampleSize="155"/>
				</measurement>
				<measurement id="782">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="770"/>
					<measurement class="rateMeasurement" id="783" rate="10" sampleSize="160"/>
				</measurement>
				<measurement id="784">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="770"/>
					<measurement class="rateMeasurement" id="785" rate="27" sampleSize="160"/>
				</measurement>
				<measurement id="786">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="772"/>
					<measurement class="rateMeasurement" id="787" rate="5" sampleSize="155"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="788"/>
		</study>
		<study id="789" studyId="McPartlin et al, 1998">
			<adverseEvents id="790">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="791">
				<arm id="792" size="183">
					<dose class="fixedDose" id="793" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="794" size="178">
					<dose class="fixedDose" id="795" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="796" value="A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice."/>
			</characteristics>
			<endpoints id="797">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="798">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="799" rate="8" sampleSize="178"/>
				</measurement>
				<measurement id="800">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="801" rate="128" sampleSize="178"/>
				</measurement>
				<measurement id="802">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="803" rate="9" sampleSize="178"/>
				</measurement>
				<measurement id="804">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="805" rate="137" sampleSize="183"/>
				</measurement>
				<measurement id="806">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="807" rate="10" sampleSize="183"/>
				</measurement>
				<measurement id="808">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="809" rate="44" sampleSize="178"/>
				</measurement>
				<measurement id="810">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="811" rate="8" sampleSize="183"/>
				</measurement>
				<measurement id="812">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="813" rate="17" sampleSize="178"/>
				</measurement>
				<measurement id="814">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="815" rate="16" sampleSize="183"/>
				</measurement>
				<measurement id="816">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="794"/>
					<measurement class="rateMeasurement" id="817" rate="21" sampleSize="178"/>
				</measurement>
				<measurement id="818">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="819" rate="30" sampleSize="183"/>
				</measurement>
				<measurement id="820">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="792"/>
					<measurement class="rateMeasurement" id="821" rate="46" sampleSize="183"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="822"/>
		</study>
		<study id="823" studyId="Mehtonen et al, 2000">
			<adverseEvents id="824">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="825">
				<arm id="826" size="75">
					<dose class="fixedDose" id="827" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="828" size="72">
					<dose class="fixedDose" id="829" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="830" value="Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group."/>
			</characteristics>
			<endpoints id="831">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="832">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="833" rate="49" sampleSize="75"/>
				</measurement>
				<measurement id="834">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="835" rate="6" sampleSize="75"/>
				</measurement>
				<measurement id="836">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="837" rate="8" sampleSize="72"/>
				</measurement>
				<measurement id="838">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="839" rate="21" sampleSize="72"/>
				</measurement>
				<measurement id="840">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="841" rate="9" sampleSize="75"/>
				</measurement>
				<measurement id="842">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="843" rate="10" sampleSize="75"/>
				</measurement>
				<measurement id="844">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="845" rate="10" sampleSize="72"/>
				</measurement>
				<measurement id="846">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="847" rate="27" sampleSize="75"/>
				</measurement>
				<measurement id="848">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="849" rate="41" sampleSize="72"/>
				</measurement>
				<measurement id="850">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="826"/>
					<measurement class="rateMeasurement" id="851" rate="21" sampleSize="75"/>
				</measurement>
				<measurement id="852">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="853" rate="5" sampleSize="72"/>
				</measurement>
				<measurement id="854">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="828"/>
					<measurement class="rateMeasurement" id="855" rate="21" sampleSize="72"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="856"/>
		</study>
		<study id="857" studyId="Montgomery et al, 2004">
			<adverseEvents id="858">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="859">
				<arm id="860" size="145">
					<dose class="fixedDose" id="861" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="862" size="148">
					<dose class="fixedDose" id="863" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="14"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="864" value="A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder."/>
			</characteristics>
			<endpoints id="865">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="866">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="867" rate="11" sampleSize="148"/>
				</measurement>
				<measurement id="868">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="869" rate="7" sampleSize="148"/>
				</measurement>
				<measurement id="870">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="871" rate="25" sampleSize="148"/>
				</measurement>
				<measurement id="872">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="873" rate="113" sampleSize="145"/>
				</measurement>
				<measurement id="874">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="875" rate="14" sampleSize="145"/>
				</measurement>
				<measurement id="876">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="877" rate="38" sampleSize="145"/>
				</measurement>
				<measurement id="878">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="879" rate="9" sampleSize="145"/>
				</measurement>
				<measurement id="880">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="881" rate="19" sampleSize="148"/>
				</measurement>
				<measurement id="882">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="883" rate="9" sampleSize="145"/>
				</measurement>
				<measurement id="884">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="885" rate="10" sampleSize="148"/>
				</measurement>
				<measurement id="886">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="862"/>
					<measurement class="rateMeasurement" id="887" rate="113" sampleSize="148"/>
				</measurement>
				<measurement id="888">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="860"/>
					<measurement class="rateMeasurement" id="889" rate="13" sampleSize="145"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="890"/>
		</study>
		<study id="891" studyId="Nemeroff et al, 1995">
			<adverseEvents id="892">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="893">
				<arm id="894" size="46">
					<dose class="fixedDose" id="895" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="896" size="49">
					<dose class="fixedDose" id="897" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="16"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="898" value="Double-blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients."/>
			</characteristics>
			<endpoints id="899"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="900">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="894"/>
					<measurement class="rateMeasurement" id="901" rate="16" sampleSize="46"/>
				</measurement>
				<measurement id="902">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="894"/>
					<measurement class="rateMeasurement" id="903" rate="15" sampleSize="46"/>
				</measurement>
				<measurement id="904">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="896"/>
					<measurement class="rateMeasurement" id="905" rate="15" sampleSize="49"/>
				</measurement>
				<measurement id="906">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="894"/>
					<measurement class="rateMeasurement" id="907" rate="7" sampleSize="46"/>
				</measurement>
				<measurement id="908">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="894"/>
					<measurement class="rateMeasurement" id="909" rate="11" sampleSize="46"/>
				</measurement>
				<measurement id="910">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="896"/>
					<measurement class="rateMeasurement" id="911" rate="6" sampleSize="49"/>
				</measurement>
				<measurement id="912">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="896"/>
					<measurement class="rateMeasurement" id="913" rate="13" sampleSize="49"/>
				</measurement>
				<measurement id="914">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="896"/>
					<measurement class="rateMeasurement" id="915" rate="13" sampleSize="49"/>
				</measurement>
				<measurement id="916">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="894"/>
					<measurement class="rateMeasurement" id="917" rate="10" sampleSize="46"/>
				</measurement>
				<measurement id="918">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="896"/>
					<measurement class="rateMeasurement" id="919" rate="7" sampleSize="49"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="920"/>
		</study>
		<study id="921" studyId="Newhouse et al, 2000">
			<adverseEvents id="922">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="923">
				<arm id="924" size="117">
					<dose class="fixedDose" id="925" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="926" size="119">
					<dose class="fixedDose" id="927" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="928" value="A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients"/>
			</characteristics>
			<endpoints id="929">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="930">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="931" rate="9" sampleSize="117"/>
				</measurement>
				<measurement id="932">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="933" rate="12" sampleSize="119"/>
				</measurement>
				<measurement id="934">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="935" rate="85" sampleSize="117"/>
				</measurement>
				<measurement id="936">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="937" rate="26" sampleSize="117"/>
				</measurement>
				<measurement id="938">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="939" rate="17" sampleSize="117"/>
				</measurement>
				<measurement id="940">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="941" rate="16" sampleSize="117"/>
				</measurement>
				<measurement id="942">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="943" rate="22" sampleSize="119"/>
				</measurement>
				<measurement id="944">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="924"/>
					<measurement class="rateMeasurement" id="945" rate="39" sampleSize="117"/>
				</measurement>
				<measurement id="946">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="947" rate="37" sampleSize="119"/>
				</measurement>
				<measurement id="948">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="949" rate="17" sampleSize="119"/>
				</measurement>
				<measurement id="950">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="951" rate="84" sampleSize="119"/>
				</measurement>
				<measurement id="952">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="926"/>
					<measurement class="rateMeasurement" id="953" rate="19" sampleSize="119"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="954"/>
		</study>
		<study id="955" studyId="Patris et al, 1996">
			<adverseEvents id="956">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="957">
				<arm id="958" size="173">
					<dose class="fixedDose" id="959" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="12"/>
				</arm>
				<arm id="960" size="184">
					<dose class="fixedDose" id="961" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="962" value="Citalopram versus fluoxetine: a double-blind, controlled, multicenter, phase II trial in patients with unipolar depression treated in general practice."/>
			</characteristics>
			<endpoints id="963"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="964">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="960"/>
					<measurement class="rateMeasurement" id="965" rate="1" sampleSize="184"/>
				</measurement>
				<measurement id="966">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="958"/>
					<measurement class="rateMeasurement" id="967" rate="6" sampleSize="173"/>
				</measurement>
				<measurement id="968">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="958"/>
					<measurement class="rateMeasurement" id="969" rate="8" sampleSize="173"/>
				</measurement>
				<measurement id="970">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="960"/>
					<measurement class="rateMeasurement" id="971" rate="10" sampleSize="184"/>
				</measurement>
				<measurement id="972">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="960"/>
					<measurement class="rateMeasurement" id="973" rate="14" sampleSize="184"/>
				</measurement>
				<measurement id="974">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="958"/>
					<measurement class="rateMeasurement" id="975" rate="6" sampleSize="173"/>
				</measurement>
				<measurement id="976">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="958"/>
					<measurement class="rateMeasurement" id="977" rate="17" sampleSize="173"/>
				</measurement>
				<measurement id="978">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="960"/>
					<measurement class="rateMeasurement" id="979" rate="7" sampleSize="184"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="980"/>
		</study>
		<study id="981" studyId="Rapaport et al, 1996">
			<adverseEvents id="982">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="983">
				<arm id="984" size="51">
					<dose class="fixedDose" id="985" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="16"/>
				</arm>
				<arm id="986" size="49">
					<dose class="fixedDose" id="987" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="988" value="A comparison of fluvoxamine and fluoxetine in the treatment of major depression."/>
			</characteristics>
			<endpoints id="989"/>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="990">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="986"/>
					<measurement class="rateMeasurement" id="991" rate="21" sampleSize="49"/>
				</measurement>
				<measurement id="992">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="984"/>
					<measurement class="rateMeasurement" id="993" rate="11" sampleSize="51"/>
				</measurement>
				<measurement id="994">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="984"/>
					<measurement class="rateMeasurement" id="995" rate="18" sampleSize="51"/>
				</measurement>
				<measurement id="996">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="986"/>
					<measurement class="rateMeasurement" id="997" rate="14" sampleSize="49"/>
				</measurement>
				<measurement id="998">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="986"/>
					<measurement class="rateMeasurement" id="999" rate="26" sampleSize="49"/>
				</measurement>
				<measurement id="1000">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="986"/>
					<measurement class="rateMeasurement" id="1001" rate="14" sampleSize="49"/>
				</measurement>
				<measurement id="1002">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="984"/>
					<measurement class="rateMeasurement" id="1003" rate="26" sampleSize="51"/>
				</measurement>
				<measurement id="1004">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="984"/>
					<measurement class="rateMeasurement" id="1005" rate="6" sampleSize="51"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1006"/>
		</study>
		<study id="1007" studyId="Rudolph and Feiger, 1999">
			<adverseEvents id="1008">
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1009">
				<arm id="1010" size="100">
					<dose class="fixedDose" id="1011" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="1012" size="103">
					<dose class="fixedDose" id="1013" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1014" value="A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression."/>
			</characteristics>
			<endpoints id="1015">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1016">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1012"/>
					<measurement class="rateMeasurement" id="1017" rate="6" sampleSize="103"/>
				</measurement>
				<measurement id="1018">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1012"/>
					<measurement class="rateMeasurement" id="1019" rate="19" sampleSize="103"/>
				</measurement>
				<measurement id="1020">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1010"/>
					<measurement class="rateMeasurement" id="1021" rate="54" sampleSize="100"/>
				</measurement>
				<measurement id="1022">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1010"/>
					<measurement class="rateMeasurement" id="1023" rate="26" sampleSize="100"/>
				</measurement>
				<measurement id="1024">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1010"/>
					<measurement class="rateMeasurement" id="1025" rate="26" sampleSize="100"/>
				</measurement>
				<measurement id="1026">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1012"/>
					<measurement class="rateMeasurement" id="1027" rate="51" sampleSize="103"/>
				</measurement>
				<measurement id="1028">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1012"/>
					<measurement class="rateMeasurement" id="1029" rate="20" sampleSize="103"/>
				</measurement>
				<measurement id="1030">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1010"/>
					<measurement class="rateMeasurement" id="1031" rate="14" sampleSize="100"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1032"/>
		</study>
		<study id="1033" studyId="Schatzberg et al, 2002">
			<adverseEvents id="1034">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1035">
				<arm id="1036" size="120">
					<dose class="fixedDose" id="1037" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="1038" size="126">
					<dose class="fixedDose" id="1039" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="17"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1040" value="Double-blind randomized comparison of mirtazapine and paroxetine in elderly depressed patients"/>
			</characteristics>
			<endpoints id="1041">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1042">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1043" rate="69" sampleSize="120"/>
				</measurement>
				<measurement id="1044">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1045" rate="14" sampleSize="120"/>
				</measurement>
				<measurement id="1046">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1047" rate="24" sampleSize="120"/>
				</measurement>
				<measurement id="1048">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1049" rate="19" sampleSize="126"/>
				</measurement>
				<measurement id="1050">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1051" rate="22" sampleSize="120"/>
				</measurement>
				<measurement id="1052">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1053" rate="20" sampleSize="126"/>
				</measurement>
				<measurement id="1054">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1055" rate="81" sampleSize="126"/>
				</measurement>
				<measurement id="1056">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1057" rate="31" sampleSize="120"/>
				</measurement>
				<measurement id="1058">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1059" rate="20" sampleSize="126"/>
				</measurement>
				<measurement id="1060">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1036"/>
					<measurement class="rateMeasurement" id="1061" rate="18" sampleSize="120"/>
				</measurement>
				<measurement id="1062">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1063" rate="8" sampleSize="126"/>
				</measurement>
				<measurement id="1064">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1038"/>
					<measurement class="rateMeasurement" id="1065" rate="15" sampleSize="126"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1066"/>
		</study>
		<study id="1067" studyId="Schone and Ludwig, 1993">
			<adverseEvents id="1068">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1069">
				<arm id="1070" size="54">
					<dose class="fixedDose" id="1071" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="1072" size="52">
					<dose class="fixedDose" id="1073" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1074" value="A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression"/>
			</characteristics>
			<endpoints id="1075">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1076">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1077" rate="2" sampleSize="52"/>
				</measurement>
				<measurement id="1078">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1079" rate="6" sampleSize="52"/>
				</measurement>
				<measurement id="1080">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1081" rate="7" sampleSize="52"/>
				</measurement>
				<measurement id="1082">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1083" rate="6" sampleSize="52"/>
				</measurement>
				<measurement id="1084">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1085" rate="3" sampleSize="52"/>
				</measurement>
				<measurement id="1086">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1072"/>
					<measurement class="rateMeasurement" id="1087" rate="9" sampleSize="52"/>
				</measurement>
				<measurement id="1088">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1089" rate="5" sampleSize="54"/>
				</measurement>
				<measurement id="1090">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1091" rate="4" sampleSize="54"/>
				</measurement>
				<measurement id="1092">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1093" rate="4" sampleSize="54"/>
				</measurement>
				<measurement id="1094">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1095" rate="20" sampleSize="54"/>
				</measurement>
				<measurement id="1096">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1097" rate="1" sampleSize="54"/>
				</measurement>
				<measurement id="1098">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1070"/>
					<measurement class="rateMeasurement" id="1099" rate="5" sampleSize="54"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1100"/>
		</study>
		<study id="1101" studyId="Sechter et al, 1999">
			<adverseEvents id="1102">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1103">
				<arm id="1104" size="118">
					<dose class="fixedDose" id="1105" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="19"/>
				</arm>
				<arm id="1106" size="120">
					<dose class="fixedDose" id="1107" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1108" value="A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients."/>
			</characteristics>
			<endpoints id="1109">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1110">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1106"/>
					<measurement class="rateMeasurement" id="1111" rate="8" sampleSize="120"/>
				</measurement>
				<measurement id="1112">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1104"/>
					<measurement class="rateMeasurement" id="1113" rate="27" sampleSize="118"/>
				</measurement>
				<measurement id="1114">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1106"/>
					<measurement class="rateMeasurement" id="1115" rate="76" sampleSize="120"/>
				</measurement>
				<measurement id="1116">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1104"/>
					<measurement class="rateMeasurement" id="1117" rate="86" sampleSize="118"/>
				</measurement>
				<measurement id="1118">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1104"/>
					<measurement class="rateMeasurement" id="1119" rate="4" sampleSize="118"/>
				</measurement>
				<measurement id="1120">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1106"/>
					<measurement class="rateMeasurement" id="1121" rate="20" sampleSize="120"/>
				</measurement>
				<measurement id="1122">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1106"/>
					<measurement class="rateMeasurement" id="1123" rate="2" sampleSize="120"/>
				</measurement>
				<measurement id="1124">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1106"/>
					<measurement class="rateMeasurement" id="1125" rate="4" sampleSize="120"/>
				</measurement>
				<measurement id="1126">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1104"/>
					<measurement class="rateMeasurement" id="1127" rate="3" sampleSize="118"/>
				</measurement>
				<measurement id="1128">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1104"/>
					<measurement class="rateMeasurement" id="1129" rate="6" sampleSize="118"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1130"/>
		</study>
		<study id="1131" studyId="Silverstone and Ravindran, 1999">
			<adverseEvents id="1132">
				<adverseEvent ref="8"/>
				<adverseEvent ref="6"/>
			</adverseEvents>
			<arms id="1133">
				<arm id="1134" size="128">
					<dose class="fixedDose" id="1135" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="1136" size="121">
					<dose class="fixedDose" id="1137" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1138" value="Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety."/>
			</characteristics>
			<endpoints id="1139">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1140">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1136"/>
					<measurement class="rateMeasurement" id="1141" rate="30" sampleSize="121"/>
				</measurement>
				<measurement id="1142">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1134"/>
					<measurement class="rateMeasurement" id="1143" rate="41" sampleSize="128"/>
				</measurement>
				<measurement id="1144">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1134"/>
					<measurement class="rateMeasurement" id="1145" rate="49" sampleSize="128"/>
				</measurement>
				<measurement id="1146">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1136"/>
					<measurement class="rateMeasurement" id="1147" rate="22" sampleSize="121"/>
				</measurement>
				<measurement id="1148">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1136"/>
					<measurement class="rateMeasurement" id="1149" rate="77" sampleSize="121"/>
				</measurement>
				<measurement id="1150">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1134"/>
					<measurement class="rateMeasurement" id="1151" rate="84" sampleSize="128"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1152"/>
		</study>
		<study id="1153" studyId="Tylee et al, 1997">
			<adverseEvents id="1154">
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1155">
				<arm id="1156" size="171">
					<dose class="fixedDose" id="1157" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="20"/>
				</arm>
				<arm id="1158" size="170">
					<dose class="fixedDose" id="1159" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="15"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1160" value="A double-blind, randomized, 12-week comparison study of the safety and efficacy of venlafaxine and fluoxetine in moderate to severe depression in general practice."/>
			</characteristics>
			<endpoints id="1161">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1162">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1156"/>
					<measurement class="rateMeasurement" id="1163" rate="67" sampleSize="171"/>
				</measurement>
				<measurement id="1164">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1158"/>
					<measurement class="rateMeasurement" id="1165" rate="58" sampleSize="170"/>
				</measurement>
				<measurement id="1166">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1156"/>
					<measurement class="rateMeasurement" id="1167" rate="59" sampleSize="171"/>
				</measurement>
				<measurement id="1168">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1156"/>
					<measurement class="rateMeasurement" id="1169" rate="7" sampleSize="171"/>
				</measurement>
				<measurement id="1170">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1156"/>
					<measurement class="rateMeasurement" id="1171" rate="19" sampleSize="171"/>
				</measurement>
				<measurement id="1172">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1158"/>
					<measurement class="rateMeasurement" id="1173" rate="11" sampleSize="170"/>
				</measurement>
				<measurement id="1174">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1158"/>
					<measurement class="rateMeasurement" id="1175" rate="31" sampleSize="170"/>
				</measurement>
				<measurement id="1176">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1158"/>
					<measurement class="rateMeasurement" id="1177" rate="11" sampleSize="170"/>
				</measurement>
				<measurement id="1178">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1158"/>
					<measurement class="rateMeasurement" id="1179" rate="29" sampleSize="170"/>
				</measurement>
				<measurement id="1180">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1156"/>
					<measurement class="rateMeasurement" id="1181" rate="19" sampleSize="171"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1182"/>
		</study>
		<study id="1183" studyId="Weihs et al, 2000">
			<adverseEvents id="1184">
				<adverseEvent ref="8"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="9"/>
			</adverseEvents>
			<arms id="1185">
				<arm id="1186" size="52">
					<dose class="fixedDose" id="1187" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="18"/>
				</arm>
				<arm id="1188" size="48">
					<dose class="fixedDose" id="1189" quantity="0.0">
						<unit value="MILLIGRAMS_A_DAY"/>
					</dose>
					<drug class="drug" ref="11"/>
				</arm>
			</arms>
			<characteristics class="characteristics">
				<TITLE class="string" id="1190" value="Bupropion sustained release versus paroxetine for the treatment of depression in the elderly."/>
			</characteristics>
			<endpoints id="1191">
				<endpoint ref="3"/>
			</endpoints>
			<indication class="indication" ref="1"/>
			<measurements>
				<measurement id="1192">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1193" rate="11" sampleSize="52"/>
				</measurement>
				<measurement id="1194">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1195" rate="6" sampleSize="48"/>
				</measurement>
				<measurement id="1196">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1197" rate="6" sampleSize="48"/>
				</measurement>
				<measurement id="1198">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1199" rate="40" sampleSize="52"/>
				</measurement>
				<measurement id="1200">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1201" rate="7" sampleSize="52"/>
				</measurement>
				<measurement id="1202">
					<outcomeMeasure class="adverseEvent" ref="6"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1203" rate="7" sampleSize="52"/>
				</measurement>
				<measurement id="1204">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1205" rate="10" sampleSize="52"/>
				</measurement>
				<measurement id="1206">
					<outcomeMeasure class="adverseEvent" ref="5"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1207" rate="3" sampleSize="48"/>
				</measurement>
				<measurement id="1208">
					<outcomeMeasure class="adverseEvent" ref="7"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1209" rate="17" sampleSize="48"/>
				</measurement>
				<measurement id="1210">
					<outcomeMeasure class="endpoint" ref="3"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1211" rate="34" sampleSize="48"/>
				</measurement>
				<measurement id="1212">
					<outcomeMeasure class="adverseEvent" ref="9"/>
					<arm ref="1188"/>
					<measurement class="rateMeasurement" id="1213" rate="6" sampleSize="48"/>
				</measurement>
				<measurement id="1214">
					<outcomeMeasure class="adverseEvent" ref="8"/>
					<arm ref="1186"/>
					<measurement class="rateMeasurement" id="1215" rate="8" sampleSize="52"/>
				</measurement>
			</measurements>
			<notes/>
			<populationCharacteristics id="1216"/>
		</study>
	</studies>
	<metaAnalyses id="1217">
		<networkMetaAnalysis id="1218" name="Hansen Diarrhea network">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="5"/>
			<armEntries>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="20"/>
					<arm ref="78"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="18"/>
					<arm ref="80"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="19"/>
					<arm ref="28"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="18"/>
					<arm ref="26"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<networkMetaAnalysis id="1219" name="Hansen Dizziness network">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="6"/>
			<armEntries>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="19"/>
					<arm ref="28"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="18"/>
					<arm ref="26"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="15"/>
					<arm ref="1136"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="20"/>
					<arm ref="1134"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<randomEffectsMetaAnalysis id="1220" name="Hansen Fluox - Parox">
			<indication ref="1"/>
			<outcomeMeasure class="endpoint" ref="3"/>
			<armEntries>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="517"/>
					<drug ref="15"/>
					<arm ref="522"/>
				</armEntry>
				<armEntry>
					<study ref="517"/>
					<drug ref="18"/>
					<arm ref="520"/>
				</armEntry>
			</armEntries>
		</randomEffectsMetaAnalysis>
		<randomEffectsMetaAnalysis id="1221" name="Hansen Fluox - Sertr">
			<indication ref="1"/>
			<outcomeMeasure class="endpoint" ref="3"/>
			<armEntries>
				<armEntry>
					<study ref="217"/>
					<drug ref="15"/>
					<arm ref="222"/>
				</armEntry>
				<armEntry>
					<study ref="217"/>
					<drug ref="19"/>
					<arm ref="220"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</randomEffectsMetaAnalysis>
		<randomEffectsMetaAnalysis id="1222" name="Hansen Fluox - Venla">
			<indication ref="1"/>
			<outcomeMeasure class="endpoint" ref="3"/>
			<armEntries>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="15"/>
					<arm ref="400"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="20"/>
					<arm ref="398"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="15"/>
					<arm ref="1136"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="20"/>
					<arm ref="1134"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
			</armEntries>
		</randomEffectsMetaAnalysis>
		<networkMetaAnalysis id="1223" name="Hansen HAM-D network">
			<indication ref="1"/>
			<outcomeMeasure class="endpoint" ref="3"/>
			<armEntries>
				<armEntry>
					<study ref="217"/>
					<drug ref="15"/>
					<arm ref="222"/>
				</armEntry>
				<armEntry>
					<study ref="217"/>
					<drug ref="19"/>
					<arm ref="220"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="20"/>
					<arm ref="78"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="18"/>
					<arm ref="80"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="15"/>
					<arm ref="1136"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="20"/>
					<arm ref="1134"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="15"/>
					<arm ref="400"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="20"/>
					<arm ref="398"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
				<armEntry>
					<study ref="517"/>
					<drug ref="15"/>
					<arm ref="522"/>
				</armEntry>
				<armEntry>
					<study ref="517"/>
					<drug ref="18"/>
					<arm ref="520"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<networkMetaAnalysis id="1224" name="Hansen Headache Network">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="7"/>
			<armEntries>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="20"/>
					<arm ref="78"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="18"/>
					<arm ref="80"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="19"/>
					<arm ref="28"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="18"/>
					<arm ref="26"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="15"/>
					<arm ref="400"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="20"/>
					<arm ref="398"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<networkMetaAnalysis id="1225" name="Hansen Insomnia Network">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="8"/>
			<armEntries>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="15"/>
					<arm ref="1136"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="20"/>
					<arm ref="1134"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<networkMetaAnalysis id="1226" name="Hansen Nausea network">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="9"/>
			<armEntries>
				<armEntry>
					<study ref="625"/>
					<drug ref="15"/>
					<arm ref="630"/>
				</armEntry>
				<armEntry>
					<study ref="625"/>
					<drug ref="18"/>
					<arm ref="628"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="20"/>
					<arm ref="78"/>
				</armEntry>
				<armEntry>
					<study ref="75"/>
					<drug ref="18"/>
					<arm ref="80"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="15"/>
					<arm ref="258"/>
				</armEntry>
				<armEntry>
					<study ref="253"/>
					<drug ref="18"/>
					<arm ref="256"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="15"/>
					<arm ref="926"/>
				</armEntry>
				<armEntry>
					<study ref="921"/>
					<drug ref="19"/>
					<arm ref="924"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="15"/>
					<arm ref="1106"/>
				</armEntry>
				<armEntry>
					<study ref="1101"/>
					<drug ref="19"/>
					<arm ref="1104"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="20"/>
					<arm ref="826"/>
				</armEntry>
				<armEntry>
					<study ref="823"/>
					<drug ref="19"/>
					<arm ref="828"/>
				</armEntry>
				<armEntry>
					<study ref="417"/>
					<drug ref="15"/>
					<arm ref="422"/>
				</armEntry>
				<armEntry>
					<study ref="417"/>
					<drug ref="18"/>
					<arm ref="420"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="19"/>
					<arm ref="28"/>
				</armEntry>
				<armEntry>
					<study ref="23"/>
					<drug ref="18"/>
					<arm ref="26"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="15"/>
					<arm ref="400"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="20"/>
					<arm ref="398"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="20"/>
					<arm ref="792"/>
				</armEntry>
				<armEntry>
					<study ref="789"/>
					<drug ref="18"/>
					<arm ref="794"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="15"/>
					<arm ref="538"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="19"/>
					<arm ref="534"/>
				</armEntry>
				<armEntry>
					<study ref="531"/>
					<drug ref="18"/>
					<arm ref="536"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="15"/>
					<arm ref="1072"/>
				</armEntry>
				<armEntry>
					<study ref="1067"/>
					<drug ref="18"/>
					<arm ref="1070"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="15"/>
					<arm ref="170"/>
				</armEntry>
				<armEntry>
					<study ref="165"/>
					<drug ref="19"/>
					<arm ref="168"/>
				</armEntry>
			</armEntries>
		</networkMetaAnalysis>
		<randomEffectsMetaAnalysis id="1227" name="Insomnia, venla-fluox">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="8"/>
			<armEntries>
				<armEntry>
					<study ref="1131"/>
					<drug ref="15"/>
					<arm ref="1136"/>
				</armEntry>
				<armEntry>
					<study ref="1131"/>
					<drug ref="20"/>
					<arm ref="1134"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
			</armEntries>
		</randomEffectsMetaAnalysis>
		<randomEffectsMetaAnalysis id="1228" name="nausea, venla-fluox">
			<indication ref="1"/>
			<outcomeMeasure class="adverseEvent" ref="9"/>
			<armEntries>
				<armEntry>
					<study ref="1007"/>
					<drug ref="15"/>
					<arm ref="1012"/>
				</armEntry>
				<armEntry>
					<study ref="1007"/>
					<drug ref="20"/>
					<arm ref="1010"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="15"/>
					<arm ref="400"/>
				</armEntry>
				<armEntry>
					<study ref="395"/>
					<drug ref="20"/>
					<arm ref="398"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="15"/>
					<arm ref="1158"/>
				</armEntry>
				<armEntry>
					<study ref="1153"/>
					<drug ref="20"/>
					<arm ref="1156"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="15"/>
					<arm ref="462"/>
				</armEntry>
				<armEntry>
					<study ref="457"/>
					<drug ref="20"/>
					<arm ref="460"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="15"/>
					<arm ref="54"/>
				</armEntry>
				<armEntry>
					<study ref="49"/>
					<drug ref="20"/>
					<arm ref="52"/>
				</armEntry>
			</armEntries>
		</randomEffectsMetaAnalysis>
	</metaAnalyses>
	<benefitRiskAnalyses id="1229">
		<benefitRiskAnalysis id="1230" name="Hansen BR analysis">
			<baseline class="drug" ref="15"/>
			<drugs id="1231">
				<drug ref="18"/>
				<drug ref="19"/>
				<drug ref="20"/>
			</drugs>
			<indication class="indication" ref="1"/>
			<metaAnalyses id="1232">
				<networkMetaAnalysis ref="1226"/>
				<networkMetaAnalysis ref="1218"/>
				<networkMetaAnalysis ref="1223"/>
				<networkMetaAnalysis ref="1225"/>
				<networkMetaAnalysis ref="1219"/>
				<networkMetaAnalysis ref="1224"/>
			</metaAnalyses>
			<outcomeMeasures id="1233">
				<endpoint ref="3"/>
				<adverseEvent ref="5"/>
				<adverseEvent ref="6"/>
				<adverseEvent ref="7"/>
				<adverseEvent ref="8"/>
				<adverseEvent ref="9"/>
			</outcomeMeasures>
		</benefitRiskAnalysis>
	</benefitRiskAnalyses>
</addis-data>
